Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis <i>in vitro</i> via VEGFR2 and its downstream signaling pathways.

Zhu, Xia; Okubo, Aya; Igari, Naoki; Ninomiya, Kentaro; Egashira, Yukari

Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis in vitro via VEGFR2 and its downstream signaling pathways.

Zhu, Xia; Okubo, Aya; Igari, Naoki; Ninomiya, Kentaro; Egashira, Yukari.

Afiliação

Zhu X; Research and Development Department, Daiwa Pharmaceutical Co., Ltd., 1650-88 Okubara-cho, Ushiku-shi, Ibaraki 300-1283, Japan.
Okubo A; Research and Development Department, Daiwa Pharmaceutical Co., Ltd., 1650-88 Okubara-cho, Ushiku-shi, Ibaraki 300-1283, Japan.
Igari N; Research and Development Department, Daiwa Pharmaceutical Co., Ltd., 1650-88 Okubara-cho, Ushiku-shi, Ibaraki 300-1283, Japan.
Ninomiya K; Marketing Planning & Support, Daiwa Pharmaceutical Co., Ltd., Tokyo, Japan.
Egashira Y; Laboratory of Food and Nutrition, Graduate School of Horticulture, Chiba University, Matsudo, Japan.

Biosci Microbiota Food Health ; 36(2): 45-53, 2017.

Article em En | MEDLINE | ID: mdl-28439487